MPPP (opioid):
246
Ziporyn, T. A growing industry and menace: Makeshift laboratory’s designer drugs JAMA, 12 Dec 1986, 256 (22), 3061–3063. 486 kB. https://doi.org/10.1001/jama.1986.03380220011003
Janssen, PAJ; Eddy, NB. Compounds related to pethidine--IV. New general chemical methods of increasing the analgesic activity of pethidine J. Med. Chem., 1 Feb 1960, 2 (1), 31–45. 520 kB. https://doi.org/10.1021/jm50008a003 #R-1143
Harper, NJ; Simmonds, AB. Flurocompounds related to the reversed esters of pethidine J. Med. Chem., 1 Apr 1959, 1 (2), 181–185. 291 kB. https://doi.org/10.1021/jm50003a006 #22
Passie, T; Brandt, SD. Self-experiments with psychoactive substances: A historical perspective In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 69-110. 563 kB. https://doi.org/10.1007/164_2018_177 #MPPP
4-MeO-α-PBP · 4′-Methoxy-α-(pyrrolidin-1-yl)butanophenone
ED-pyr-A · α-Methyl-3,4-ethylenedioxyphenethylpyrrolidine
4′-Hydroxy-α-(pyrrolidin-1-yl)valerophenone · O-2418
4-Me-MPH · 4-Methylmethylphenidate
3-MeO-2′-Oxo-PCE · MXE · Methoxetamine
3-Methoxy-PPPO · 3′-Methoxy-α-(piperidin-1-yl)propanophenone
N-Cyclopentyl-3-methoxycathinone